CD8A and colorectal carcinoma: For HCT-116, the results showed a 2.57-fold decrease in CD8 T cells and a 1.4-fold increase in the proportion of plasma B cells, while the proportion of naïve B cells showed a decrease in the HCT-116 CARD11-transfected cell line, suggesting that plasma B cells may play a role in CRC progression.